top of page


CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects


CEBINA was founded with the aim of creating, nurturing, and promoting early-stage life sciences companies, to develop new medicines and cutting-edge technologies.


With decades-long experience in pharmaceutical product development and biotech entrepreneurship, our team supports our internal projects and resident companies with cutting edge facilities and tailor-made services throughout all stages of company development.


For each new project, CEBINA undertakes extensive due diligence to identify projects with the highest potential, offering attractive, de-risked opportunities for investors.

CEBINA covid square.png

02 May 2022

CEBINA Announces Positive Results of a Phase 2 Clinical Study with COVID-19 patients and Azelastine Nasal Spray Published in a Peer-Reviewed Scientific Journal

Read more

DL square for CEBINA website.png

07 March 2023

Danube Labs: Call for Proposals - April 2023

Read more

CEBINA covid square.png

04 July 2022

CEBINA publishes data demonstrating the anti-histamine azelastine inhibits infection by  major variants of SARS-CoV-2

Read more


Karl-Farkas-Gasse 22

1030 Vienna, Austria

bottom of page